Magnolia Medical Applied sciences, Inc. (“Magnolia Medical”), inventors of the Steripath® Preliminary Specimen Diversion Machine® (ISDD®) household of merchandise, in the present day introduced it filed a movement for everlasting injunction within the U.S. District Court docket for the District of Delaware on September 9, 2022, that will prohibit Kurin, Inc. (“Kurin”) from the continued sale of the infringing Kurin Lock merchandise.
The submitting follows two latest jury verdicts in Magnolia Medical’s favor. The primary verdict discovered that Kurin infringed Magnolia Medical’s U.S. Patent No. 10,039,483, utilizing the corporate’s patented revolutionary know-how with out permission. The second verdict rejected Kurin’s makes an attempt to invalidate the asserted claims and awarded vital damages for the sale of the infringing Kurin Lock product, together with a 17.7% royalty.
“We’ve invested over a decade in pioneering and proving the scientific worth of our know-how. Defending our worthwhile mental property portfolio and the numerous sources that we have now devoted to scientific analysis and product innovation to forestall the misdiagnosis of bloodstream infections together with sepsis is vital to make sure that all sufferers and hospitals have entry to and profit from Magnolia Medical’s unique evidence-based know-how,” mentioned Greg Bullington, CEO of Magnolia Medical.
Steripath® is the one FDA 510(okay)-cleared platform particularly indicated to scale back blood tradition contamination,1 and Magnolia Medical’s platform gives the one all-in-one units that meet the CDC’s new tips to scale back blood tradition contamination.2,3 A everlasting injunction granted within the U.S. District Court docket for the District of Delaware would prohibit Kurin from persevering with to infringe Magnolia Medical’s patent and stop Kurin from manufacturing, utilizing, promoting, providing on the market, and/or importing the Kurin Lock product in the US.
“Whereas we’re gratified by the jury’s unanimous infringement verdict in opposition to Kurin, we consider this enforcement motion will lastly put an finish to Kurin’s illegal enterprise ways and make clear any confusion out there,” mentioned Bullington. “We’ve made no settlement with Kurin that will allow Kurin to proceed promoting its infringing Kurin Lock. We don’t license our proprietary know-how and haven’t agreed to any license with Kurin. We are going to proceed to vigorously defend the substantial efforts and sources that we have now invested over the previous decade in scientific analysis, product growth, market growth, and our mental property portfolio.”
The Steripath® Preliminary Specimen Diversion Machine® platform gives the one all-in-one units which can be clinically confirmed to fulfill the ENA, INS, CDC, and CLSI evidence-based greatest follow tips to scale back blood tradition contamination.2,3,4,5,6 Thus far, 20 scientific research have been accomplished supporting the scientific and value effectiveness of Steripath. All research reported sustained contamination charges of 1% or much less utilizing Steripath, as much as a 31% discount in vancomycin days of remedy, and as a lot as a 12-fold lower in false-positive central line-associated blood stream infections (CLABSIs) over prolonged durations of time.7,8,9
Steripath has been adopted by a whole bunch of U.S. hospitals and healthcare techniques to deal with the issue of blood tradition contamination, which might result in sepsis misdiagnosis leading to pointless, extended, and dangerous antibiotic therapy, prolonged size of hospital keep, false-positive CLABSIs, and wasted healthcare sources.
About Magnolia Medical Applied sciences
Magnolia Medical Applied sciences develops, manufactures, and markets revolutionary blood and bodily fluid assortment units to facilitate vital enhancements within the accuracy, consistency, and predictability of important laboratory exams. Magnolia Medical invented and patented the Preliminary Specimen Diversion Approach® (ISDT®) and Preliminary Specimen Diversion Machine® (ISDD®) for blood tradition assortment and contamination prevention. The corporate has amassed an mental property portfolio, together with greater than 100 issued methodology, equipment, and design patents with greater than 70 extra patent functions pending. For extra info, go to www.magnolia-medical.com.
Indicated to scale back the frequency of blood tradition contamination when contaminants are current, in comparison with normal methodology controls with out diversion.
CDC. Blood Tradition Contamination Prevention Actions: An Overview of An infection Management and Antibiotic Stewardship Packages Working with the Scientific Laboratory. July 2022.
CDC. Nationwide Electronic mail Replace to Clinicians. Clinicians: Use this information to lower blood tradition contamination charges. July 22, 2022.
CLSI. Ideas and Procedures for Blood Cultures. 2nd Ed. CLSI Guideline M47. Scientific and Laboratory Requirements Institute; 2022.
Vanhoy MA, Horigan A, Kaiser J, et al. Emergency Nurses Affiliation (ENA). Scientific follow guideline: prevention of blood tradition contamination. 2020.
Gorski LA, Hadaway L, Hagle ME, et al. Infusion remedy requirements of follow, eighth version. J Infus Nurs. 2021 Jan-Feb 01;44(1S Suppl 1): S1-S224.doi: 10.1097/NAN.0000000000000396.
Information on file.
Nielsen LE, Nguyen Okay, Wahl CK, et al. Preliminary Specimen Diversion Machine® reduces blood tradition contamination and vancomycin use in tutorial medical heart. J Hosp Infect. 2021;117. doi:https://doi.org/10.1016/j.jhin.2021.10.017.
Tompkins LS, et al. Attending to zero: influence of a tool to scale back blood tradition contamination and false-positive central line-associated blood stream infections. Submitted to ICHE August 2022.
SOURCE Magnolia Medical Applied sciences